MDxHealth SA [Rocket]

Overview

MDxHealth SA

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/11/2023	6-K	Quarterly results
10/10/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
10/03/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
08/23/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
08/10/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/05/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/03/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19
Revenues	22.2	18.5	11.8
Revenue growth	20.5%	56.6%
Cost of goods sold	0.0	0.0	0.0
Gross profit	22.2	18.5	11.8
Gross margin	100.0%	100.0%	100.0%
Selling, general and administrative	0.0	0.0	0.0
EBIT	0.0	0.0	0.0
EBIT margin	0.0%	0.0%	0.0%
Pre-tax income	0.0	0.0	0.0
Income taxes	0.0	0.0	0.0
Net income	0.0	0.0	0.0
Net margin	0.0%	0.0%	0.0%


EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy